Skip to main content
Site logo

Main navigation

  • Home
  • About Anne Marie
  • My Views
  • News
  • COVID-19
  • My Plan
  • Contact Me
Site logo

Cannabis for Medicinal Use

  • Tweet

---------------------------------------------------------------------------------------------------------------------

Cannabis for Medicinal Use

Thank you for contacting me about medicinal cannabis.

There is strong scientific evidence that cannabis is a drug which can harm people’s mental and physical health, and damage communities. However recent cases have shown the need to look more closely at the use of cannabis-based medicine in the healthcare sector in the UK. This is why the Government decided it was appropriate to review the scheduling of cannabis.

The review has taken place in two parts. Professor Dame Sally Davies took forward the first part of the review, considering the evidence available for the medicinal and therapeutic benefits of cannabis-based medicines. This informed which cannabis-based medicines should be taken forward to part two of the review. The second part of the review was led by the Advisory Council on the Misuse of Drugs (ACMD) which provided an assessment based on the balance of harms and public health needs, of what, if anything, should be rescheduled.  

I very much welcome the decision of the Home Secretary, Sajid Javid, to reschedule these products. This decision means that senior clinicians will be able to prescribe the medicines to patients with an exceptional clinical need. The ACMD will carry out a longer-term review on rescheduling and make further recommendations within 12 months.

It is crucial that this country keeps in step with the latest scientific evidence, so that patients and their families have access to the most appropriate course of medical treatment.

The Government has been absolutely clear that this decision is in no way a first step to the legalisation of cannabis for recreational use. There are no plans to legalise cannabis and the penalties for unauthorised supply and possession will remain unchanged. We must not set a dangerous precedent or weaken our ability to keep dangerous drugs off our streets.

Thank you again for contacting me.

---------------------------------------------------------------------------------------------------------------------

My Views

  • Brexit
  • Business, Energy & Industrial Strategy
  • Cabinet Office
  • Defence
  • Digital, Culture, Media and Sport
  • Education
  • Environment, Food and Rural Affairs
  • Foreign and Commonwealth
  • Health & Social Care
    • Abortion - Changes During the Pandemic
    • Alcohol Harm
    • Allergies
    • Alzheimer's Society's Fix Dementia Care campaign (Dec 2018)
    • Arthritis and the Impact of COVID-19
    • Asthma prescription charges
    • Baby Loss
    • Bite Back Better Campaign
    • Bowel Cancer Awareness Month
    • Brain Cancer
    • Breast Cancer
    • Calorie Labelling and Eating Disorders
    • Cancer Treatment During COVID-19 Outbreak
    • Cancer Research Funding
    • Cancer Workforce
    • Cannabis for Medicinal Use
    • Carers' Week and Respite Plan for Unpaid Carers
    • Charity Funded Research (British Heart Foundation)
    • Chief Dental Officer - No Confidence Campaign
    • Childhood Obesity
    • Children's Services Funding
    • Coronavirus Vaccine and Intellectual Property - EDM 1451
    • Continuity of Carer - Maternity
    • Crisis Pregnancies
    • Cystic Fibrosis Prescription Charges
    • Dementia and the Impact of COVID-19
    • Diabetes and Diabetes UK Report Launch
    • Early Medical Abortion (At Home)
    • Eating Disorders - Waiting Times
    • End of Free Coronavirus Testing
    • Endometriosis
    • Foetal Pain
    • Foetal Viability Event
    • Group B Streptococcus
    • GP Recruitment and Retention
    • Health and Care Bill ('Save our NHS' Campaign)
    • Heart Disease
    • HIV and 2030 Goal
    • Hospice UK Parliamentary Event 6th July 2022
    • Hospital Parking Charges
    • Integrated Care Systems (ICS)
    • IVF
    • Junior Doctors' Pay
    • Leukemia Care (Watch Wait Worry Campaign)
    • Liver Disease
    • Loneliness and Disability
    • Lymphomatic Leukemia - #WatchWaitWorry Campaign
    • Maternity Care - Continuity of Carer
    • ME/Chronic Fatigue Syndrome
    • Mental Capacity (Amendment) Bill - Liberty Protection Safeguards
    • Motor Neurone Disease
    • Neglected Tropical Diseases
    • Neurological Conditions
    • NHS Pay
    • NHS Staff Catering EDM 816
    • NHS Workforce
    • NHS Workforce & Brexit
    • Palliative Care
    • Pancreatic Cancer
    • Radiotherapy
    • Sarcoma UK
    • Serenity Integrated Mentoring (SIM)
    • Shielding Support - COVID-19
    • Smoking and Cancer Research UK 'Smokefree MP' Campaign
    • Social Care Reform
    • Terminal Illness and Access to Benefits
    • Trodelvy and EDM 419
    • Vaccine Damage Payment Scheme
    • VAT on Sunscreen Products
    • Winterbourne View
    • Women's Health Strategy and Miscarriage
    • World Arthritis Day, Joint Replacement Surgery
    • Young People's Mental Health
  • Home Office
  • Housing, Communities and Local Government
  • International Development
  • International Trade
  • Transport
  • Treasury
  • Work and Pensions

Anne Marie Morris MP for Newton Abbot

Footer

  • About RSS
  • Accessibility
  • Cookies
  • Privacy
  • About Anne Marie
Promoted by Dennis Flynn on behalf of Anne Marie Morris, both of 2 Salisbury House, Salisbury Road, Newton Abbot TQ12 2DF
Copyright 2022 Anne Marie Morris MP for Newton Abbot. All rights reserved.
Powered by Bluetree